Clinical practice guidelines and specific antigen immunotherapy
Fornadley, J.A.
Otolaryngologic Clinics of North America 36(5): 789-802 V
2003
ISSN/ISBN: 0030-6665 PMID: 14743773 Document Number: 554780
Allergy immunotherapy is a safe, effective treatment modality in selected patients. The length of therapy and the wide variety of patient sensitivities make it difficult to develop and test evidence-based guidelines in all areas of immunotherapy. A review of techniques and the evidence supporting them is provided in this article.
Document emailed within 1 workday
Related Documents
Senna, G.E.; Makatsori, M.; Schiappoli, M.; Dama, A.R. 2011: Subcutaneous allergen specific immunotherapy: best clinical practice as cornerstone for future development European Annals of Allergy and Clinical Immunology 43(5): 135-140Ward, J.E.; Grieco, V. 1996: Why we need guidelines for guidelines: a study of the quality of clinical practice guidelines in Australia Medical Journal of Australia 165(10): 574-576
García, B.E.; Sanz, M.L.; Wong, E.; Oehling, A. 1988: Effect of immunotherapy on antigen-specific IgG4 in asthmatics sensitive to D. pteronyssinus Allergologia et Immunopathologia 16(6): 379-383
Moulias, R.; Goust, J.M.; Reinert, P.; Fournel, J.J.; Deville-Chabrolle, A.; Duong, N.; Muller-Berat, C.N.; Berthaux, P. 1973: Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice La Nouvelle Presse Medicale 2(20): 1341-1344
Kinikli, G.ül.; Ateş, A.şk.; Turgay, M.; Aydoğan, N.; Tokgöz, G.ün. 2006: Serum-soluble Fas antigen level in patients with allergic rhinitis: its relation to specific immunotherapy Allergy and Asthma Proceedings 27(2): 145-147
Ashley, M.P.; Zbar, B.; Hunter, J.T.; Rapp, H.J.; Sugimoto, T. 1980: Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery Cancer Research 40(11): 4197-4203
Kurth, K.H.; Marquet, R.; Zwartendijk, J.; Warnaar, S.O. 1987: Autologous anticancer antigen preparation for specific immunotherapy in advanced renal cell carcinoma European Urology 13(1-2): 103-109
Calderón Sandubet, E.; Cotos Cancas, R.; Marín León, I.; Briones Pérez de la Blanca, E.; Pérez Cano, B.; Grilo Reina, A. 2000: Mapping the scientific evidence for bedside care to unstable angina. A preliminary step to develop clinical guidelines. The name of the study group CAMBIE Change in the Medical services based on the clinical practice guidelines Medicina Clinica 114 Suppl. 2: 19-23
Helou, A.; Perleth, M.; Bitzer, E.M.; Dörning, H.; Schwartz, F.W. 1998: Methodological quality of clinical practice guidelines in Germany: results of a systemic assessment of guidelines presented on the Internet Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 92(6): 421-428
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Murphy, R.N. 1996: Legal and practical impact of clinical practice guidelines on nursing and medical practice Advances in wound care: the journal for prevention and healing 9(5): 31-34
Jackson, C.L.; de Jong, I.C. 1999: Clinical practice guidelines and general practice: the sleeping giant in Australian healthcare integration? Medical Journal of Australia 171(2): 91-93
Heselmans, A.; Donceel, P.; Aertgeerts, B.; Van de Velde, S.; Ramaekers, D. 2009: The attitude of Belgian social insurance physicians towards evidence-based practice and clinical practice guidelines BMC family practice 10: 64
Vargin, V.V.; Semenov, B.F. 1989: The effect of antigen-specific suppression induced by flaviviruses on the formation of an antigen-specific immunologic defect Voprosy Virusologii 34(4): 446-449
Chen, W.; Reese, V.A.; Cheever, M.A. 1990: Adoptively transferred antigen-specific T cells can be grown and maintained in large numbers in vivo for extended periods of time by intermittent restimulation with specific antigen plus IL-2 Journal of Immunology 144(10): 3659-3666
Fernández-Távora, L.; Moreno, C.; Martín, S.; Rico, P. 2003: The optimal immunotherapy cluster schedule in clinical practice Journal of Investigational Allergology and Clinical Immunology 13(3): 193-201
Finkelman, F.D.; Villacreses, N.; Holmes, J.M. 1992: Role of antigen-specific T cell help in the generation of in vivo antibody responses. II. Sustained antigen-specific T cell help is required to induce a specific antibody response Journal of Immunology 149(12): 3845-3850
Lyng, K.Marie. 2010: From clinical practice guidelines, to clinical guidance in practice--implications for design of computerized guidance Studies in health technology and informatics 157: 169-174
Asher, I.; Mahlab-Guri, K.; Sthoeger, Z. 2013: The immunological mechanisms contributing to the clinical efficacy of allergen specific immunotherapy (SIT) in allergic diseases Harefuah 152(9): 529
Hussain, F.; Abidi, S.Sibte.Raza. 2005: A knowledge management framework to morph clinical cases with clinical practice guidelines Studies in health technology and informatics 116: 731-736